Femasys Inc. (FEMY) vs Scienture Holdings, Inc. (SCNX)
A side-by-side comparison of Femasys Inc. and Scienture Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FEMY
Femasys Inc.
$2.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCNX
Scienture Holdings, Inc.
$3.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FEMY vs SCNX
growth of $100 · dividends reinvested · last 2yFEMY -90.6% (-69.3%/yr)SCNX -98.0% (-85.9%/yr)FEMY compounded faster over this window
FEMY SCNX
FEMY vs SCNX: by the numbers
- •FEMY is the larger company ($6M vs $6M market cap).
- •Both run net losses; FEMY's is the smaller (-534.27% vs -4620.92% net margin).
- •FEMY grew revenue faster over the past five years (12.97% vs -42.69% CAGR).
Metrics side by side
Valuation
| Metric | FEMY | SCNX |
|---|---|---|
| P/S ratio | 2.73 | 7.44 |
| P/B ratio | 1.56 | 0.10 |
Profitability
| Metric | FEMY | SCNX |
|---|---|---|
| Gross margin | 61.96% | 76.80% |
| Operating margin | -763.90% | -3763.78% |
| Net margin | -534.27% | -4620.92% |
| ROE | -304.78% | -59.21% |
| ROIC | -209.05% | -15.99% |
Growth (annualized)
| Metric | FEMY | SCNX |
|---|---|---|
| Revenue CAGR (5Y) | 12.97% | -42.69% |
| Total return CAGR (5Y) | -57.27% | N/A |
Frequently asked
- Which has grown faster, FEMY or SCNX?
- Over the past five years, FEMY grew revenue faster — FEMY at a 12.97% CAGR versus SCNX at -42.69%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.